Issue: June 2019
June 06, 2019
1 min read
Save
This article is more than 5 years old. Information may no longer be current.
EXTEND
Issue: June 2019
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Researchers assessed whether administering IV tissue plasminogen activator between 3 and 9 hours after the onset of stroke improved outcomes compared with placebo.